Your browser doesn't support javascript.
loading
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study.
Lim, Sung Hee; Hong, Jung Yong; Park, Joon Oh; Park, Young Suk; Kim, Seung Tae.
Affiliation
  • Lim SH; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Hong JY; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Park JO; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Park YS; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea shty1@skku.deu.
Anticancer Res ; 43(9): 4161-4167, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37648323
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Carcinoma in Situ / Cholangiocarcinoma / Gallbladder Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Carcinoma in Situ / Cholangiocarcinoma / Gallbladder Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article